K
Kalevi Pyörälä
Researcher at European Society of Cardiology
Publications - 217
Citations - 57873
Kalevi Pyörälä is an academic researcher from European Society of Cardiology. The author has contributed to research in topics: Diabetes mellitus & Myocardial infarction. The author has an hindex of 87, co-authored 217 publications receiving 56802 citations.
Papers
More filters
Journal ArticleDOI
Cholesterol-Lowering Therapy in Women and Elderly Patients With Myocardial Infarction or Angina Pectoris Findings From the Scandinavian Simvastatin Survival Study (4S)
Tatu A. Miettinen,Kalevi Pyörälä,Anders G. Olsson,Thomas Musliner,Thomas J. Cook,Ole Faergeman,Kåre Berg,Terje R. Pedersen,John Kjekshus +8 more
TL;DR: Cholesterol lowering with simvastatin produced similar reductions in relative risk for major coronary events in women compared with men and in elderly (> or = 65 years of age) compared with younger patients.
Journal Article
European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force Of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts).
Guy De Backer,Guy De Backer,Ettore Ambrosioni,Knut Borch-Johnsen,Carlos Brotons,Renata Cifkova,Jean Dallongeville,Shah Ebrahim,Ole Faergeman,I. M. Graham,Giuseppe Mancia,Volkert Manger Cats,Kristina Orth-Gomér,Joep Perk,Kalevi Pyörälä,Jose L. Rodicio,Susana Sans,Vedat Sansoy,Udo Sechtem,Sigmund Silber,Troels Thomsen,David R. Wood +21 more
TL;DR: Preamble Guidelines aim to present all the relevant evidence on a particular issue in order to help physicians to weigh the benefits and risks of a particular diagnostic or therapeutic procedure and be helpful in everyday clinical decision-making.
Journal ArticleDOI
Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: subgroup analyses in the Scandinavian Simvastatin Survival Study.
Steven M. Haffner,Charles M. Alexander,Thomas J. Cook,Stephen J. Boccuzzi,Thomas Musliner,Terje R. Pedersen,John Kjekshus,Kalevi Pyörälä +7 more
TL;DR: The concept that cholesterol lowering with simvastatin therapy improves the prognosis of patients with elevated fasting glucose levels is supported and confirmed by results extending previous findings in patients with DM to a larger cohort.
Journal ArticleDOI
European guidelines on cardiovascular disease prevention in clinical practice; Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts)
Guy De Backer,Guy De Backer,Ettore Ambrosioni,Knut Borch-Johnsen,Carlos Brotons,Renata Cifkova,Jean Dallongeville,Shah Ebrahim,Ole Faergeman,I. M. Graham,Giuseppe Mancia,Volkert Manger Cats,Kristina Orth-Gomér,Joep Perk,Kalevi Pyörälä,Jose L. Rodicio,Susana Sans,Vedat Sansoy,Udo Sechtem,Sigmund Silber,Troels Thomsen,David R. Wood +21 more
TL;DR: The ESC Committee for Practice Guidelines (CPG) supervises and coordinates the preparation of new guidelines and expert consensus documents produced by task forces, expert groups or consensus panels as discussed by the authors, and is also responsible for the endorsement of these guidelines or statements.
Journal ArticleDOI
Type 2 Diabetes as a “Coronary Heart Disease Equivalent”: An 18-year prospective population-based study in Finnish subjects
TL;DR: Diabetic subjects without any prior evidence of CHD (myocardial infarction or ischemic electrocardiogram [ECG] changes or angina pectoris) indicates a higher risk than prior evidenceof CHD in nondiabetic subjects, especially in women.